Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Price (688076.SS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

214,389,612

(0.5656)%

Sinopep-Allsino Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Sinopep-Allsino Bio Pharmaceutical Co.,Ltd., a biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China. The company offers formulations, such as thymalfasin products for injection, eptifibatide injections, alogliptin benzoate tablets, and oseltamivir phosphate capsules; APIs and intermediates; and drugs for type 2 diabetes and obesity, and coronavirus. It also provides pharmaceutical research, clinical, and registration services of drugs; and undertakes CDMO/CMO pr... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $47.48-81.5
  • Market Cap 12.96B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Mr. Wei Ding
  • IPO Date: May, 20, 2021
  • Country: CN
  • Currency: CNY
  • Headquaters: No Data
  • Employees: 1545

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation